- Home
- CNMD vs CNTA Comparison
CNMD vs CNTA Comparison
Compare CNMD & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- CNTA
- Stock Information
- Founded
- CNMD 1970
- CNTA 2020
- Country
- CNMD United States
- CNTA United Kingdom
- Employees
- CNMD N/A
- CNTA N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- CNMD Health Care
- CNTA Health Care
- Exchange
- CNMD Nasdaq
- CNTA Nasdaq
- Market Cap
- CNMD 1.7B
- CNTA 2.3B
- IPO Year
- CNMD 1987
- CNTA 2021
- Fundamental
- Price
- CNMD $48.48
- CNTA $22.77
- Analyst Decision
- CNMD Hold
- CNTA Strong Buy
- Analyst Count
- CNMD 5
- CNTA 8
- Target Price
- CNMD $59.80
- CNTA $31.29
- AVG Volume (30 Days)
- CNMD 343.5K
- CNTA 1.0M
- Earning Date
- CNMD 11-05-2025
- CNTA 11-11-2025
- Dividend Yield
- CNMD 1.65%
- CNTA N/A
- EPS Growth
- CNMD 12.82
- CNTA N/A
- EPS
- CNMD 3.54
- CNTA N/A
- Revenue
- CNMD $1,326,244,000.00
- CNTA $15,000,000.00
- Revenue This Year
- CNMD $6.73
- CNTA N/A
- Revenue Next Year
- CNMD $5.45
- CNTA N/A
- P/E Ratio
- CNMD $13.67
- CNTA N/A
- Revenue Growth
- CNMD 3.94
- CNTA 118.88
- 52 Week Low
- CNMD $42.50
- CNTA $9.60
- 52 Week High
- CNMD $78.00
- CNTA $24.57
- Technical
- Relative Strength Index (RSI)
- CNMD 54.33
- CNTA 55.40
- Support Level
- CNMD $43.64
- CNTA $21.78
- Resistance Level
- CNMD $45.57
- CNTA $23.64
- Average True Range (ATR)
- CNMD 1.60
- CNTA 0.82
- MACD
- CNMD 0.51
- CNTA -0.20
- Stochastic Oscillator
- CNMD 93.64
- CNTA 52.12
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.